Answers are grounded in this paper and cite their sources.
This study provides an estimate of research and development costs for new therapeutic agents based on publicly available data. Differences from previous studies may reflect the spectrum of products analyzed, the restricted availability of data in the public domain, and differences in underlying assumptions in the cost calculations.
No takes yet. Share an insight, caveat, or question.
Wouters et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: